{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:01:07Z","timestamp":1791316867047,"version":"4.3.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060520"],"award-info":[{"award-number":["82060520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology","award":["ZYYD2022"],"award-info":[{"award-number":["ZYYD2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99909-6","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T07:13:57Z","timestamp":1748589237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The value of GULP1 in cancer prognosis and immunotherapy, validated from pan-cancer analysis to pancreatic cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Wangbiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulinaizaier","family":"Abudusaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"99909_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"99909_CR2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia, C. et al. Cancer statistics in China and united States, 2022: profiles, trends, and determinants. Chin. Med. J. (Engl). 135, 584\u2013590 (2022).","journal-title":"Chin. Med. J. (Engl)"},{"key":"99909_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41591-022-01746-x","volume":"28","author":"RC Fitzgerald","year":"2022","unstructured":"Fitzgerald, R. C., Antoniou, A. C., Fruk, L. & Rosenfeld, N. The future of early cancer detection. Nat. Med. 28, 666\u2013677 (2022).","journal-title":"Nat. Med."},{"key":"99909_CR4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice, C. et al. Global, regional, and National Cancer incidence, mortality, years of life lost, years lived with disability, and Disability-Adjusted life-Years for 29 Cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 5, 1749\u20131768 (2019).","journal-title":"JAMA Oncol."},{"key":"99909_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","volume":"14","author":"L Lin","year":"2021","unstructured":"Lin, L. et al. Global, regional, and National cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019. J. Hematol. Oncol. 14, 197 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"99909_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram, I. & Bray, F. Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070. Nat. Rev. Clin. Oncol. 18, 663\u2013672 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99909_CR7","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029\u20133030 (2021).","journal-title":"Cancer"},{"key":"99909_CR8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0960-9822(00)80062-7","volume":"9","author":"E Smits","year":"1999","unstructured":"Smits, E., Van Criekinge, W., Plaetinck, G. & Bogaert, T. The human homologue of Caenorhabditis elegans CED-6 specifically promotes phagocytosis of apoptotic cells. Curr. Biol. 9, 1351\u20131354 (1999).","journal-title":"Curr. Biol."},{"key":"99909_CR9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0960-9822(00)80061-5","volume":"9","author":"QA Liu","year":"1999","unstructured":"Liu, Q. A. & Hengartner, M. O. Human CED-6 encodes a functional homologue of the Caenorhabditis elegans engulfment protein CED-6. Curr. Biol. 9, 1347\u20131350 (1999).","journal-title":"Curr. Biol."},{"key":"99909_CR10","doi-asserted-by":"crossref","first-page":"12081","DOI":"10.1074\/jbc.M600621200","volume":"281","author":"RS Kiss","year":"2006","unstructured":"Kiss, R. S. et al. The lipoprotein receptor-related protein-1 (LRP) adapter protein GULP mediates trafficking of the LRP ligand prosaposin, leading to sphingolipid and free cholesterol accumulation in late endosomes and impaired efflux. J. Biol. Chem. 281, 12081\u201312092 (2006).","journal-title":"J. Biol. Chem."},{"key":"99909_CR11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cub.2007.03.014","volume":"17","author":"Z Ma","year":"2007","unstructured":"Ma, Z., Nie, Z., Luo, R., Casanova, J. E. & Ravichandran, K. S. Regulation of Arf6 and ACAP1 signaling by the PTB-domain-containing adaptor protein GULP. Curr. Biol. 17, 722\u2013727 (2007).","journal-title":"Curr. Biol."},{"key":"99909_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.canlet.2018.06.030","volume":"433","author":"L Maldonado","year":"2018","unstructured":"Maldonado, L. et al. Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1. Cancer Lett. 433, 242\u2013251 (2018).","journal-title":"Cancer Lett."},{"key":"99909_CR13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/cancers13225838","volume":"13","author":"C Paret","year":"2021","unstructured":"Paret, C. et al. Identification of an Immunogenic Medulloblastoma-Specific fusion involving EPC2 and GULP1. Cancers (Basel). 13, 2072\u20136694 (2021).","journal-title":"Cancers (Basel)"},{"key":"99909_CR14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41419-023-06000-x","volume":"14","author":"D Yan","year":"2023","unstructured":"Yan, D. et al. The APC\/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer. Cell. Death Dis. 14, 516 (2023).","journal-title":"Cell. Death Dis."},{"key":"99909_CR15","doi-asserted-by":"crossref","first-page":"eaba0443","DOI":"10.1126\/scisignal.aba0443","volume":"13","author":"M Hayashi","year":"2020","unstructured":"Hayashi, M. et al. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. Sci. Signal. 13, eaba0443 (2020).","journal-title":"Sci. Signal."},{"key":"99909_CR16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00262-020-02739-w","volume":"70","author":"Z Saidak","year":"2021","unstructured":"Saidak, Z. et al. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment. Cancer Immunol. Immunother. 70, 923\u2013933 (2021).","journal-title":"Cancer Immunol. Immunother"},{"key":"99909_CR17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cell.2018.03.027","volume":"173","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. A Pan-Cancer analysis of enhancer expression in nearly 9000 patient samples. Cell 173, 386\u2013399e312 (2018).","journal-title":"Cell"},{"key":"99909_CR18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020).","journal-title":"Nat. Biotechnol."},{"key":"99909_CR19","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen, W. et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta 1, e36 (2022).","journal-title":"iMeta"},{"key":"99909_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","volume":"180","author":"DP Nusinow","year":"2020","unstructured":"Nusinow, D. P. et al. Quantitative proteomics of the Cancer cell line encyclopedia. Cell 180, 387\u2013402e316 (2020).","journal-title":"Cell"},{"key":"99909_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia (New York NY). 25, 18\u201327 (2022).","journal-title":"Neoplasia (New York NY)"},{"key":"99909_CR22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nmeth.1607","volume":"8","author":"K Colwill","year":"2011","unstructured":"Colwill, K. & Gr\u00e4slund, S. A roadmap to generate renewable protein binders to the human proteome. Nat. Methods. 8, 551\u2013558 (2011).","journal-title":"Nat. Methods"},{"key":"99909_CR23","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35, 4200\u20134202 (2019).","journal-title":"Bioinformatics"},{"key":"99909_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov"},{"key":"99909_CR25","doi-asserted-by":"crossref","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu, C. J. et al. GSCA: an integrated platform for gene set cancer analysis at genomic, Pharmacogenomic and Immunogenomic levels. Brief. Bioinform. 24, bbac558 (2023).","journal-title":"Brief. Bioinform"},{"key":"99909_CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur, V. et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10, 277\u2013288 (2018).","journal-title":"Epigenomics"},{"key":"99909_CR27","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan, H. et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 47, D900\u2013d908 (2019).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR28","doi-asserted-by":"crossref","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun, D. et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 49, D1420\u2013d1430 (2021).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR29","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013d613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR30","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013w560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR31","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013w514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21 (2020).","journal-title":"Genome Med."},{"key":"99909_CR33","doi-asserted-by":"crossref","first-page":"D1391","DOI":"10.1093\/nar\/gkab804","volume":"50","author":"Z Zeng","year":"2022","unstructured":"Zeng, Z. et al. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 50, D1391\u2013d1397 (2022).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR34","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41401-023-01079-6","volume":"44","author":"SA Kov\u00e1cs","year":"2023","unstructured":"Kov\u00e1cs, S. A., Fekete, J. T. & Gy\u0151rffy, B. Predictive biomarkers of immunotherapy response with Pharmacological applications in solid tumors. Acta Pharmacol. Sin. 44, 1879\u20131889 (2023).","journal-title":"Acta Pharmacol. Sin"},{"key":"99909_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees, M. G. et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat. Chem. Biol. 12, 109\u2013116 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"99909_CR36","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of drug sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"99909_CR37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","volume":"6","author":"J Smith","year":"2020","unstructured":"Smith, J., Sen, S., Weeks, R. J., Eccles, M. R. & Chatterjee, A. Promoter DNA hypermethylation and Paradoxical gene activation. Trends cancer. 6, 392\u2013406 (2020).","journal-title":"Trends cancer"},{"key":"99909_CR38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama, A. & Nakanishi, M. Navigating the DNA methylation landscape of cancer. Trends Genet. 37, 1012\u20131027 (2021).","journal-title":"Trends Genet."},{"key":"99909_CR39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu, J., Peng, Y. & Wei, W. Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell. Biol. 32, 30\u201344 (2022).","journal-title":"Trends Cell. Biol."},{"key":"99909_CR40","doi-asserted-by":"crossref","first-page":"106376","DOI":"10.1016\/j.phrs.2022.106376","volume":"183","author":"L Ren","year":"2022","unstructured":"Ren, L. et al. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. Pharmacol. Res. 183, 106376 (2022).","journal-title":"Pharmacol. Res."},{"key":"99909_CR41","doi-asserted-by":"crossref","first-page":"e003091","DOI":"10.1136\/jitc-2021-003091","volume":"10","author":"R Cristescu","year":"2022","unstructured":"Cristescu, R. et al. Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors. J. Immunother. Cancer. 10, e003091 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"99909_CR42","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.annonc.2020.09.017","volume":"31","author":"PG Pili\u00e9","year":"2020","unstructured":"Pili\u00e9, P. G., George, A. & Yap, T. A. Patient selection biomarker strategies for PARP inhibitor therapy. Ann. Oncol. 31, 1603\u20131605 (2020).","journal-title":"Ann. Oncol."},{"key":"99909_CR43","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","volume":"10","author":"L Monteran","year":"2019","unstructured":"Monteran, L. & Erez, N. The dark side of fibroblasts: Cancer-Associated fibroblasts as mediators of immunosuppression in the tumor microenvironment. Front. Immunol. 10, 1835 (2019).","journal-title":"Front. Immunol."},{"key":"99909_CR44","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood, B., Najafi, M. & Mortezaee, K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review. J. Cell. Physiol. 234, 8509\u20138521 (2019).","journal-title":"J. Cell. Physiol."},{"key":"99909_CR45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","volume":"395","author":"GR Dagenais","year":"2020","unstructured":"Dagenais, G. R. et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet 395, 785\u2013794 (2020).","journal-title":"Lancet"},{"key":"99909_CR46","doi-asserted-by":"crossref","unstructured":"Han, B. et al. Cancer Incidence and Mortality in China, 2022 (Journal of the National Cancer Center, 2024).","DOI":"10.1016\/j.jncc.2024.01.006"},{"key":"99909_CR47","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","volume":"19","author":"N Khalaf","year":"2021","unstructured":"Khalaf, N., El-Serag, H. B., Abrams, H. R. & Thrift, A. P. Burden of pancreatic cancer: from epidemiology to practice. Clin. Gastroenterol. Hepatol. 19, 876\u2013884 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"99909_CR48","unstructured":"Wild, C., Weiderpass, E. & Stewart, B. W. World cancer Report: cancer Research for cancer Prevention (International Agency for Research on Cancer, 2020)."},{"key":"99909_CR49","doi-asserted-by":"crossref","first-page":"pkac066","DOI":"10.1093\/jncics\/pkac066","volume":"6","author":"S Arjani","year":"2022","unstructured":"Arjani, S., Saint-Maurice, P. F., Juli\u00e1n-Serrano, S., Eibl, G. & Stolzenberg-Solomon, R. Body mass index trajectories across the adult life course and pancreatic Cancer risk. JNCI cancer Spectr. 6, pkac066 (2022).","journal-title":"JNCI cancer Spectr."},{"key":"99909_CR50","doi-asserted-by":"crossref","unstructured":"Bignold, L. P. Typing, grading, and staging of cases of tumor. Principles of Tumors 279\u2013315  (2020).","DOI":"10.1016\/B978-0-12-816920-9.00010-9"},{"key":"99909_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41467-019-14085-2","volume":"11","author":"KL Marie","year":"2020","unstructured":"Marie, K. L. et al. Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis. Nat. Commun. 11, 333 (2020).","journal-title":"Nat. Commun."},{"key":"99909_CR52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","volume":"18","author":"CJ Pirozzi","year":"2021","unstructured":"Pirozzi, C. J. & Yan, H. The implications of IDH mutations for cancer development and therapy. Nat. Rev. Clin. Oncol. 18, 645\u2013661 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99909_CR53","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1016\/j.cell.2023.07.013","volume":"186","author":"Y Geffen","year":"2023","unstructured":"Geffen, Y. et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186, 3945\u20133967e3926 (2023).","journal-title":"Cell"},{"key":"99909_CR54","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.3390\/ijms22084247","volume":"22","author":"A Martisova","year":"2021","unstructured":"Martisova, A. et al. DNA methylation in solid tumors: functions and methods of detection. Int. J. Mol. Sci. 22, 4247 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"99909_CR55","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1186\/s12885-022-10227-w","volume":"22","author":"Y Inokawa","year":"2022","unstructured":"Inokawa, Y. et al. High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas. BMC Cancer. 22, 1146 (2022).","journal-title":"BMC Cancer"},{"key":"99909_CR56","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12967-020-02432-7","volume":"18","author":"B Du","year":"2020","unstructured":"Du, B., Wang, F., Jarad, B., Wang, Z. & Zhang, Y. A novel signature based on microvascular invasion predicts the recurrence of HCC. J. Transl Med. 18, 272 (2020).","journal-title":"J. Transl Med."},{"key":"99909_CR57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","volume":"15","author":"A Koch","year":"2018","unstructured":"Koch, A. et al. Analysis of DNA methylation in cancer: location revisited. Nat. Rev. Clin. Oncol. 15, 459\u2013466 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99909_CR58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","volume":"21","author":"JM Bugter","year":"2021","unstructured":"Bugter, J. M., Fenderico, N. & Maurice, M. M. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat. Rev. Cancer. 21, 5\u201321 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"99909_CR59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells10030659","volume":"10","author":"HYK Yip","year":"2021","unstructured":"Yip, H. Y. K. & Papa, A. Signaling pathways in cancer: therapeutic targets, combinatorial treatments, and new developments. Cells 10, 659 (2021).","journal-title":"Cells"},{"key":"99909_CR60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov"},{"key":"99909_CR61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang, K. et al. Glioma targeted therapy: insight into future of molecular approaches. Mol. Cancer. 21, 39 (2022).","journal-title":"Mol. Cancer"},{"key":"99909_CR62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez, K. J., Allen, B. M. & Spitzer, M. H. Systemic immunity in cancer. Nat. Rev. Cancer. 21, 345\u2013359 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"99909_CR63","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/cancers13040904","volume":"13","author":"R Talty","year":"2021","unstructured":"Talty, R. & Olino, K. Metabolism of innate immune cells in Cancer. Cancers (Basel). 13, 904 (2021).","journal-title":"Cancers (Basel)"},{"key":"99909_CR64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J. Biomed. Sci. 26, 78 (2019).","journal-title":"J. Biomed. Sci."},{"key":"99909_CR65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99909_CR66","doi-asserted-by":"crossref","first-page":"16779","DOI":"10.1038\/s41598-021-96344-1","volume":"11","author":"KW Min","year":"2021","unstructured":"Min, K. W. et al. Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis. Sci. Rep. 11, 16779 (2021).","journal-title":"Sci. Rep."},{"key":"99909_CR67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu, T. et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J. Hematol. Oncol. 12, 86 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"99909_CR68","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng, Q. et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat. Rev. Cancer. 23, 544\u2013564 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"99909_CR69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-pathmechdis-012418-013058","volume":"16","author":"S Ugel","year":"2021","unstructured":"Ugel, S., Can\u00e8, S., De Sanctis, F. & Bronte, V. Monocytes in the tumor microenvironment. Annu. Rev. Pathol. 16, 93\u2013122 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"99909_CR70","first-page":"21408","volume":"13","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Blood transfusion practices affect CD4(+) CD25(+) FOXP3(+) regulatory T cells\/t helper-17 cells and the clinical outcome of geriatric patients with hip fracture. Aging (Albany N Y). 13, 21408\u201321420 (2021).","journal-title":"Aging (Albany N Y)"},{"key":"99909_CR71","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","volume":"38","author":"S Sakaguchi","year":"2020","unstructured":"Sakaguchi, S. et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 38, 541\u2013566 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"99909_CR72","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul, M. & Ohashi, P. S. The roles of CD8(+) T cell subsets in antitumor immunity. Trends Cell. Biol. 30, 695\u2013704 (2020).","journal-title":"Trends Cell. Biol."},{"key":"99909_CR73","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","volume":"41","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with Spatial CITE-seq. Nat. Biotechnol. 41, 1405\u20131409 (2023).","journal-title":"Nat. Biotechnol."},{"key":"99909_CR74","doi-asserted-by":"crossref","first-page":"731751","DOI":"10.3389\/fimmu.2021.731751","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. The CXCL family contributes to immunosuppressive microenvironment in gliomas and assists in gliomas chemotherapy. Front. Immunol. 12, 731751 (2021).","journal-title":"Front. Immunol."},{"key":"99909_CR75","doi-asserted-by":"crossref","first-page":"694490","DOI":"10.3389\/fimmu.2021.694490","volume":"12","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Novel immune infiltrating cell signature based on cell pair algorithm is a prognostic marker in Cancer. Front. Immunol. 12, 694490 (2021).","journal-title":"Front. Immunol."},{"key":"99909_CR76","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2022.01.008","volume":"185","author":"G Morad","year":"2022","unstructured":"Morad, G., Helmink, B. A., Sharma, P. & Wargo, J. A. Hallmarks of response, resistance, and toxicity to immune checkpoint Blockade. Cell 185, 576 (2022).","journal-title":"Cell"},{"key":"99909_CR77","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat. Rev. Cancer. 21, 298\u2013312 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"99909_CR78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","volume":"14","author":"S Zhu","year":"2021","unstructured":"Zhu, S. et al. Combination strategies to maximize the benefits of cancer immunotherapy. J. Hematol. Oncol. 14, 156 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"99909_CR79","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41577-019-0271-z","volume":"20","author":"H Garner","year":"2020","unstructured":"Garner, H. & de Visser, K. E. Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nat. Rev. Immunol. 20, 483\u2013497 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"99909_CR80","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 41, 374\u2013403 (2023).","journal-title":"Cancer Cell."},{"key":"99909_CR81","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale, I., Shema, E., Loi, S. & Galluzzi, L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat. Med. 27, 212\u2013224 (2021).","journal-title":"Nat. Med."},{"key":"99909_CR82","doi-asserted-by":"crossref","first-page":"922472","DOI":"10.3389\/fgene.2022.922472","volume":"13","author":"K Liu","year":"2022","unstructured":"Liu, K. et al. Pan-cancer analysis of the prognostic and immunological role of ANLN: an onco-immunological biomarker. Front. Genet. 13, 922472 (2022).","journal-title":"Front. Genet."},{"key":"99909_CR83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper, D. J. & Balkwill, F. R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237\u2013253 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99909_CR84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-020-0122-1","volume":"4","author":"G Adam","year":"2020","unstructured":"Adam, G. et al. Machine learning approaches to drug response prediction: challenges and recent progress. NPJ Precision Oncol. 4, 19 (2020).","journal-title":"NPJ Precision Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99909-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:31:29Z","timestamp":1759167089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99909"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99909-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In this article author Wangbiao Wang was incorrectly denoted as the corresponding author, also the following information was missing from the Funding section: Tianshan Talents - Leading Talents in Science and Technology Innovation of Xinjiang Uygur Autonomous Region (2023TSLJ0038). The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19021"}}